Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Development of mutation-selective LRRK2 kinase inhibitors as precision medicine for Parkinson's disease and other diseases for which carriers are at increased risk FRONTIERS IN NEUROLOGY Lesniak, R. K., Nichols, R., Montine, T. J. 2022; 13: 1016040
View details for DOI 10.3389/fneur.2022.1016040
View details for Web of Science ID 000882461500001
View details for PubMedID 36388213
View details for PubMedCentralID PMC9643380